Cargando…

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls

BACKGROUND: Hereditary haemorrhagic telangiectasia (HHT) is inherited as an autosomal dominant trait, affects ~1 in 5,000, and causes multi-systemic vascular lesions and life-limiting complications. Life expectancy is surprisingly good, particularly for patients over 60ys. We hypothesised that indiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosman, Anna E, Devlin, Hannah L, Silva, B Maneesha, Shovlin, Claire L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891994/ https://www.ncbi.nlm.nih.gov/pubmed/24354965 http://dx.doi.org/10.1186/1750-1172-8-195

Ejemplares similares

Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia
por: Anderson, Emily, et al.
Publicado: (2022)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia
por: Shovlin, Claire L., et al.
Publicado: (2016)

7-day weighed food diaries suggest patients with hereditary hemorrhagic telangiectasia may spontaneously modify their diet to avoid nosebleed precipitants
por: Finnamore, Helen, et al.
Publicado: (2017)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasia
por: Mukhtar, Ghazel, et al.
Publicado: (2023)

Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia
por: Shovlin, Claire L.
Publicado: (2015)

Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes
por: Govani, Fatima S, et al.
Publicado: (2010)

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018)

Hereditary Hæmorrhagic Telangiectasia with Recurring Hæmaturia
por: Foggie, W. E.
Publicado: (1928)

Peliosis hepatis associated with hereditary haemorrhagic telangiectasia
por: Alessandrino, F., et al.
Publicado: (2013)

Hereditary Haemorrhagic Telangiectasia: With Report of a Case
por: McEwan, Tom
Publicado: (1948)

Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia
por: Major, Tamás, et al.
Publicado: (2019)

Hereditary haemorrhagic telangiectasia: A case report
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
por: Vorselaars, V. M. M., et al.
Publicado: (2018)

Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia
por: FIORELLA, M.L., et al.
Publicado: (2012)

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)

Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature
por: Dupuis, Olivier, et al.
Publicado: (2020)

Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia
por: Wrobeln, Anna, et al.
Publicado: (2022)

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019)

An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms
por: Arthur, Helen M., et al.
Publicado: (2022)

Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology
por: Bofarid, Sala, et al.
Publicado: (2021)

Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?
por: Shovlin, Claire L., et al.
Publicado: (2016)

Low grade mosaicism in hereditary haemorrhagic telangiectasia identified by bidirectional whole genome sequencing reads through the 100,000 Genomes Project clinical diagnostic pipeline
por: Clarke, Jessica M, et al.
Publicado: (2020)

Neurologic Manifestation as Initial Presentation in a Case of Hereditary Haemorrhagic Telangiectasia
por: Teo, Yeow Kwan, et al.
Publicado: (2010)

Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia
por: Tørring, Pernille M., et al.
Publicado: (2014)

Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience
por: Pagella, Fabio, et al.
Publicado: (2021)

Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
por: Margelidon-Cozzolino, Victor, et al.
Publicado: (2021)

Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study
por: Delagrange, Laura, et al.
Publicado: (2022)

Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
por: Faughnan, Marie E., et al.
Publicado: (2018)

Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability
por: Revuz, Sabine, et al.
Publicado: (2017)

Ischaemic Strokes in Patients with Pulmonary Arteriovenous Malformations and Hereditary Hemorrhagic Telangiectasia: Associations with Iron Deficiency and Platelets
por: Shovlin, Claire L., et al.
Publicado: (2014)

Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia
por: Chavan, Ajay, et al.
Publicado: (2012)

Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
por: Morales, Enrique, et al.
Publicado: (2012)

Endoglin is a conserved regulator of vasculogenesis in zebrafish – implications for hereditary haemorrhagic telangiectasia
por: Zhang, Ding, et al.
Publicado: (2019)

An update on the ophthalmic features in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
por: Abdolrahimzadeh, Solmaz, et al.
Publicado: (2022)

Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Therapeutic targeting of vascular malformation in a zebrafish model of hereditary haemorrhagic telangiectasia
por: Snodgrass, Ryan O., et al.
Publicado: (2023)

The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function
por: Lyster, Anne Lørup, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dt93i4n233n40gptragdq13j7c